- Home
- / Biostar Pharmaceuticals
Biostar Pharmaceuticals
Stock Price
$0
2022-08-02
Market Capitalization
$3.2 K
2022-08-02
Revenue
$2.4 M
FY, 2016
Biostar Pharmaceuticals Summary
Company Summary
- Overview
- Biostar Pharmaceuticals develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The Company’s most popular product is its XinAoxingOleanolic Acid Capsule, an over-the-counter medicine for chronic hepatitis B.
- Type
- Public
- Status
- Closed
- Founded
- 2007
- HQ
- VN | view all locations
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Hà Nội HQ
Viet Nam
Đường Khương Đình, Thượng Đình
Biostar Pharmaceuticals Financials
Summary Financials
- Net income (Q3, 2017)
- ($125.2K)
- Cash (Q3, 2017)
- $365.0K
- EBIT (Q3, 2017)
- ($573.4K)
- Enterprise value
- $2.1M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026